Cellid Co Ltd
299660
Company Profile
Business description
Cellid Co Ltd is a research and development bioventure company. The company is developing immunotherapeutic vaccines, CeliVax. The CeliVax is a personalized vaccine which uses patient's own cells.
Contact
1 Gwanak-ro, Gwanak-gu
142 Suite 504
Korea Seoul National University Building
seoul08826
KORT: +82 232857861
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
56
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,913.90 | 352.20 | 4.66% |
| CAC 40 | 7,204.12 | 341.10 | 4.97% |
| DAX 40 | 20,774.37 | 1,103.49 | 5.61% |
| Dow JONES (US) | 39,868.35 | 740.10 | -1.82% |
| FTSE 100 | 7,989.99 | 310.51 | 4.04% |
| HKSE | 20,681.78 | 417.29 | 2.06% |
| NASDAQ | 16,635.58 | 489.39 | -2.86% |
| Nikkei 225 | 34,609.00 | 2,894.97 | 9.13% |
| NZX 50 Index | 12,201.43 | 394.88 | 3.34% |
| S&P 500 | 5,330.61 | 126.29 | -2.31% |
| S&P/ASX 200 | 7,709.60 | 334.60 | 4.54% |
| SSE Composite Index | 3,223.64 | 36.83 | 1.16% |